Integrated screening and catch-up vaccination in UK primary care
Research type
Research Study
Full title
Optimising the design and delivery of integrated screening and catch-up vaccination for migrant health; an in-depth interview study and process evaluation in UK primary care.
IRAS ID
278689
Contact name
Sally Hargreaves
Contact email
Sponsor organisation
St Georges' University of London
Duration of Study in the UK
3 years, 5 months, 1 days
Research summary
This study aims to seek those tasked with seeing migrant patients at a primary care level, GPs and practice nurses, receptionists, practice managers, and health-care assistants, current experience and views on delivering infectious disease screening and catch-up vaccination. We aim to further elucidate the perceived barriers and possible facilitators to acting on the current guidelines with UK GP practices. It also aims to receive feedback on prototype catch-up vaccination and screening tools that have been developed by our group and others which incorporate current guidance. We will explore how these tools could work within the screening, treatment, and care pathway, and the views and concerns of key front-line staff on implementation. These new tools have been developed with PHE, GPs, practice nurses, and migrants and facilitate screening for latent and active TB, HIV, hepatitis B and C, strongyloidiasis, Chagas disease and schistosomiasis, and ensure delivery of vaccines for measles, mumps, rubella, tetanus, diphtheria, polio, and meningitis to under-immunised migrants.
The overall aim of this research is to seek the views and concerns of front-line GPs and practices nurses, and other members of staff, around the feasibility of delivering integrated screening and catch-up vaccination of migrants into routine primary care, alongside seeking views on a specific prompting tools that have been developed as part of the GP’s electronic records system as part of a process evaluation to ensure they can be robustly embedded in primary care screening and treatment pathways. This will generate feasibility data needed to inform a multi-site trial and grant application to develop and test a complex intervention in UK primary care.
This highly innovative research will have important and impactful consequences by reducing health inequalities and impact on the NHS, and contributing to national targets for infection control and vaccination.REC name
N/A
REC reference
N/A